Act 7 of 1997 (Credit Creation)

Act 7 of 1997 established the Pennsylvania Research and Development tax credit to incentivize businesses to increase their innovation-related expenditures within the Commonwealth by offering a credit against state tax liabilities. This legislation, codified as Article XVII-B of the Tax Reform Code of 1971, provides a dual-rate system that rewards incremental increases in qualified research spending over a calculated base amount, specifically favoring small businesses through higher credit rates and dedicated funding set-asides.

The enactment of Act 7 on May 7, 1997, represented a fundamental shift in the economic development strategy of Pennsylvania, moving toward a model where the Commonwealth “creates” fiscal assets in the form of tax credits to drive private sector behavior. While the term “credit creation” is often discussed in macroeconomic theory as the process by which commercial banks generate liquidity through the issuance of demand deposits, in the specific context of Act 7, it refers to the legal birth of a transferable fiscal certificate. This certificate represents a government-verified commitment to waive future revenue in exchange for immediate investment in the state’s technological infrastructure. The creation of these credits functions as a non-monetary currency within the state’s corporate tax ecosystem, allowing firms—particularly those in pre-revenue or startup phases—to monetize their research activities even before they achieve profitability.

The Evolution of Article XVII-B and the Legislative Intent of Act 7

The primary intent of the Research and Development (R&D) tax credit provision was to encourage taxpayers to increase R&D expenditures within the Commonwealth in order to enhance economic growth and high-wage job retention. Prior to 1997, Pennsylvania lacked a competitive state-level incentive that mirrored the federal research credit, which placed local firms at a disadvantage compared to neighbors in states with more robust incentive programs. Act 7 addressed this by adding Article XVII-B to the Tax Reform Code of 1971, creating a permanent mechanism for the Department of Revenue to approve and issue tax credits based on qualified Pennsylvania research expenses.

The legislative journey of Act 7 has been marked by several critical expansions and adjustments to its administrative framework. Originally, the program was governed by a sunset provision, which meant it was scheduled to expire after taxable years ending in December 2004. However, recognizing the long-term benefits of the program, the General Assembly intervened multiple times: Act 89 of 2002 extended the sunset to 2006, and Act 116 of 2006 further pushed the date to 2016. Ultimately, Act 85 of 2016 repealed the sunset date entirely, making the Pennsylvania R&D tax credit a permanent fixture of the state’s tax code.

The Growth of the Annual Tax Credit Cap

To manage the fiscal impact on the Commonwealth’s budget, Act 7 initially imposed a total annual cap of $15 million in credits. As the program became oversubscribed, the legislature responded by increasing this cap to support more applicants and larger research initiatives. The following table illustrates the historical trajectory of the funding limits and the specific set-asides for small businesses, which have consistently comprised 20% of the total available pool.

Legislative Act	Effective Period	Total Program Cap	Small Business Set-Aside (20%)
Act 7 of 1997	1997 – 2010	$15,000,000	$3,000,000
Act 85 of 2016	2011 – 2021	$55,000,000	$11,000,000
Act 53 of 2022	2022 – Present	$60,000,000	$12,000,000

This $60 million cap is legally protected through June 30, 2025, ensuring that the incentive remains stable and predictable for corporate planning purposes. The mandatory 20% set-aside for small businesses is a critical component of the “credit creation” logic, as it prevents large multinational corporations from consuming the entire fiscal allocation, thereby nurturing the state’s entrepreneurial ecosystem.

The Conceptual Framework of “Credit Creation” Under Act 7

To understand the meaning of “Credit Creation” in the context of Act 7 of 1997, one must distinguish it from traditional banking and monetary theories. In the banking sector, credit creation is an accounting phenomenon where a bank records an asset (the loan) and a corresponding liability (the deposit), effectively expanding the money supply. In contrast, the credit creation authorized by Act 7 is a fiscal phenomenon. It is the process by which the Department of Revenue converts a business’s qualifying expenses into a restricted, liquid asset.

This fiscal credit creation involves three distinct stages:

1. Validation: The Department of Revenue verifies that the research was “qualified” and conducted specifically within Pennsylvania borders.
2. Certification: The state issues an official award letter, which creates a legal right to reduce tax liability. This letter is the physical manifestation of the created credit.
3. Monetization: Through the Assignment Program, the created credit can be sold to a third party, transforming a tax-offset right into immediate cash liquidity for the original awardee.

This process effectively creates a “tax-advantaged currency” that circulates between innovative firms and profitable corporations. The Commonwealth acts as the central issuer of this currency, controlling the supply through the $60 million annual cap and the demand through the 75% offset limitation placed on buyers.

Statutory Definitions and Compliance Standards

The Pennsylvania R&D credit is built upon the definitions found in Section 41 of the Internal Revenue Code (IRC), but with strict geographic constraints. Section 1702-B of the Tax Reform Code of 1971 defines “Pennsylvania qualified research and development” as research conducted exclusively in the Commonwealth that meets the federal requirements under IRC § 41(d).

The Four-Part Test for Qualified Research

For an activity to lead to the creation of a tax credit under Act 7, it must satisfy the federal “Four-Part Test,” which has been adopted into Pennsylvania state law.

1. Permissible Purpose: The research must be related to developing a new or improved business component, such as a product, process, software, or formula, intended for sale or use in the taxpayer’s business.
2. Elimination of Uncertainty: The activity must be intended to discover information to eliminate uncertainty regarding the capability, method, or appropriate design for developing or improving the business component.
3. Process of Experimentation: The taxpayer must engage in a systematic process of experimentation, which includes modeling, simulation, systematic trial and error, or evaluating alternatives.
4. Technological in Nature: The process of experimentation must fundamentally rely on the principles of physical or biological sciences, engineering, or computer science.

Categories of Qualified Research Expenses (QREs)

The Department of Revenue identifies four primary categories of costs that are eligible for inclusion in the credit calculation.

Expense Category	Eligibility Details	Sourcing Rule
Direct Wages	Taxable wages for employees performing or supervising research.	Must be PA-based employees.
Supplies	Tangible property (non-depreciable) consumed in the research process.	Must be consumed in PA research.
Contract Research	65% of amounts paid to third-party entities for research services.	Research must be performed in PA.
Computer/Cloud Costs	Rental or lease costs for computers used in research activities.	Applies to cloud-based dev environments.

Notably, general administrative costs, capital equipment (buildings/land), and research conducted outside of Pennsylvania are strictly excluded. The Department of Revenue requires a detailed itemization of these expenses by project location to ensure that no out-of-state activities are subsidized by Pennsylvania taxpayers.

The Incremental Credit Calculation and the “Base Amount” Methodology

Pennsylvania utilizes an “incremental” credit model, meaning the credit is only awarded for research spending that exceeds a firm’s historical baseline. This ensures that the state is incentivizing new investment rather than merely subsidizing existing operations.

Methodology for Calculating the Pennsylvania Base Amount

The “Pennsylvania Base Amount” is the threshold that current-year spending must cross. According to Department of Revenue guidance and the Tax Reform Code, the base amount is the greater of two figures:

• The Average of Prior Years: The average of Pennsylvania qualified research expenses for the four taxable years preceding the credit year.
• The 50% Rule: 50% of the current year’s Pennsylvania qualified research expenses.

For a startup with no prior research history, the average is zero, and the base amount effectively becomes 50% of the current year’s QREs. This “50% floor” ensures that even a company with massive, unprecedented growth can only receive a credit on a maximum of half of its total current-year research spending.

The Dual-Rate Structure: Large vs. Small Businesses

Act 7 provides a significant premium for small businesses to facilitate their growth. A “Small Business” is defined as an entity with a net book value of assets totaling less than $5 million at the start or end of the taxable year.

• Large Businesses: Receive a tentative credit equal to 10% of the QREs in excess of the base amount.
• Small Businesses: Receive a tentative credit equal to 20% of the QREs in excess of the base amount.

The proration process further complicates these figures. Because total requested credits exceed the $60 million cap, the Department must reduce each award proportionally. In 2024, large businesses received roughly 41.1% of their calculated tentative credit, while small businesses received 100% of their requests because their specific $12 million set-aside was not oversubscribed.

Administrative Guidance and the Role of State Revenue Offices

The administration of the R&D tax credit is a joint effort between the Pennsylvania Department of Revenue (DOR) and the Department of Community and Economic Development (DCED). The DOR handles the application and verification of research expenses, while the DCED manages the sale and assignment of the credits.

The myPATH Application Process and Tax Clearance

Taxpayers must submit their application through the myPATH online portal between August 1 and December 1. A critical component of this process is “tax clearance.” Act 43 of 2017 authorized the DOR to perform rigorous clearance checks on all applicants to ensure they are fully compliant with all state tax laws. This check extends to any individual or entity with a 20% or greater ownership interest in the applicant company. If the company or its major owners owe back taxes or have unfiled returns, the R&D credit application will be rejected.

Restricted Tax Credit Bulletin 2024-01

The Department of Revenue issued Bulletin 2024-01 to clarify the lifecycle of “restricted” credits like the R&D credit. This guidance is essential for corporate controllers to understand how credits impact their ledgers over time.

1. FIFO Application: Credits must be applied on a First-In-First-Out (FIFO) basis. The oldest credits in a taxpayer’s account are used first to satisfy liabilities, which helps prevent credits from expiring at the end of their 15-year carryforward period.
2. Order of Satisfaction: Restricted credits are applied before any cash payments. This means that if a taxpayer has a $10,000 liability and a $10,000 R&D credit, the credit satisfies the debt, and any estimated tax payments previously made in cash can be refunded or carried forward to the next year.
3. Personal Income Tax Rules: For individuals claiming the credit, the R&D credit is applied after the Tax Forgiveness Credit and any Resident Credits for taxes paid to other states.

The Credit Assignment Program: Monetizing the Created Asset

The ability to sell an unused credit is what makes the Pennsylvania R&D program uniquely valuable for technology startups. Act 46 of 2003 established the legal framework for this secondary market.

Seller and Buyer Dynamics

A company that cannot use its credit (the “Seller”) must file an application with the DCED to assign the credit to a “Buyer”.

• Seller Prerequisite: The seller must first file its state tax return for the year the credit was approved and apply the credit against any existing liability. Only the “unused” portion can be sold.
• Buyer Offset Limit: A buyer may only use the purchased R&D credit to offset up to 75% of its tax liability for the year of purchase.
• Non-Carryforward for Buyers: While the original awardee can carry the credit forward for 15 years, the buyer must use it in the year it is transferred. Purchased credits cannot be carried forward, carried back, or resold.

Term	Original Awardee (Seller)	Purchaser (Buyer)
Carryforward	15 Years	0 Years (Must use in purchase year)
Offset Limit	100% (for years after 2005)	75%
Resale	Allowed once	Prohibited

This secondary market has seen substantial activity, with historical data showing that credits often retain over 90% of their face value in sales, providing an essential source of non-dilutive capital for Pennsylvania’s tech sector.

Case Study and Example: Calculation and Application of the Credit

To demonstrate the application of the law and the Department’s guidance, consider a hypothetical Pennsylvania-based software firm, “InnoTech LLC,” which qualifies as a small business.

Step 1: Data Collection for the Application

InnoTech LLC reports the following Pennsylvania-based QREs over a five-year period.

Tax Year	Pennsylvania QREs	Asset Value
Year -4	$1,000,000	$2,000,000
Year -3	$1,200,000	$2,500,000
Year -2	$1,500,000	$3,000,000
Year -1	$1,800,000	$3,500,000
Current Year	$3,000,000	$4,000,000

Step 2: Calculating the Pennsylvania Base Amount

InnoTech must determine its baseline.

• Average of prior 4 years: ($1.0M + $1.2M + $1.5M + $1.8M) / 4 = $1,375,000.
• 50% of Current Year: $3,000,000 * 0.50 = $1,500,000.

The Base Amount is the greater of the two: $1,500,000.

Step 3: Determining the Tentative Credit

Excess QREs = Current QREs ($3,000,000) – Base Amount ($1,500,000) = $1,500,000.

Because InnoTech’s assets are under $5 million, it uses the 20% small business rate.

Tentative Credit = $1,500,000 * 20% = $300,000.

Step 4: Final Award and Proration

InnoTech submits its application by December 1. The Department of Revenue calculates that the total requested tentative credits from small businesses is $10 million, which is within the $12 million set-aside. InnoTech receives a final award of $300,000.

Step 5: Lifecycle Application and Sale (Bulletin 2024-01)

In the award year, InnoTech has a Pennsylvania tax liability of $50,000.

1. Application: The first $50,000 of the credit is used to satisfy the liability.
2. Unused Portion: $250,000 remains in carryforward.
3. Assignment: InnoTech applies to the DCED to sell the remaining $250,000. A buyer, “HeavyCorp,” purchases the credit for $225,000 (90% value).
4. Buyer Use: HeavyCorp has a $400,000 tax liability. It can only use the credit to offset 75% ($300,000). It applies the full $250,000 credit and pays the remaining $150,000 in cash.

Oversight and Integrity: Lessons from the 2019 Grand Jury Report

The “creation” of $60 million in tax credits annually presents a significant temptation for fraud. A 2019 Grand Jury investigation uncovered a scheme involving 20 shell companies that claimed over $10 million in R&D and Keystone Innovation Zone (KIZ) credits. These companies had no employees or actual research facilities; they were mere paper entities designed to harvest credits and sell them for cash.

As a result of this investigation, the Commonwealth implemented several “integrity” measures that now define the oversight guidance for the R&D credit:

• Mandatory Site Visits: The Department of Revenue and DCED may conduct on-site audits at the physical addresses provided in the application to ensure research activities are actually occurring.
• Expanded Reporting: Act 46 of 2003 and subsequent updates require the DOR to report the names of all awardees and the amounts they utilized to the General Assembly annually.
• Broker Registration: To prevent money laundering and fraudulent transfers, all tax credit brokers must now register with the Department of Revenue.
• Documentation Retention: Taxpayers must maintain detailed records of the process of experimentation and technical solutions for at least five years.

The Interaction with Federal Tax Changes: The 2022-2025 Context

The landscape for the Pennsylvania R&D tax credit was significantly altered by the federal Tax Cuts and Jobs Act (TCJA) of 2017. Starting in 2022, the TCJA required businesses to amortize R&D expenses over five years for domestic research and fifteen years for foreign research, rather than deducting them immediately.

This change created a “tax drag” for many Pennsylvania companies, as their taxable income increased due to the loss of the immediate deduction. However, Pennsylvania’s R&D tax credit (Act 7) became even more critical during this period as a primary tool for offsetting this increased tax burden. New legislative proposals in 2025, referred to as the “One Big Beautiful Bill” in industry circles, aim to restore immediate expensing at the state level and provide retroactive refunds for 2022-2024 for small businesses, further enhancing the value of the credit creation process.

Final Thoughts: The Strategic Importance of Act 7 for the Commonwealth

The Research and Development Tax Credit Law, established by Act 7 of 1997, is a sophisticated fiscal instrument that has successfully incentivized billions of dollars in private sector investment. By aligning state definitions with federal standards while maintaining a strict focus on Pennsylvania-based activities, the law ensures that the Commonwealth’s tax expenditures result in tangible local economic benefits.

The “credit creation” process authorized by this act provides more than just tax relief; it creates a liquid financial asset that supports the entire lifecycle of a business, from the initial pre-revenue stages where credits are sold for survival capital, to the mature stages where they offset high corporate net income taxes. Through administrative guidance like Bulletin 2024-01 and the rigorous oversight mandated by the 2019 Grand Jury findings, the Department of Revenue has built a framework that prioritizes both economic growth and fiscal integrity. As Pennsylvania looks toward 2025 and beyond, the R&D tax credit will remain the cornerstone of its strategy to attract and retain the high-technology industries that define the modern economy.